Fennec Pharmaceuticals (FENC) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Fennec Pharmaceuticals (FENC) over the last 15 years, with Q3 2025 value amounting to -$0.02.
- Fennec Pharmaceuticals' EPS (Weighted Average and Diluted) rose 9047.62% to -$0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.25, marking a year-over-year decrease of 15000.0%. This contributed to the annual value of -$0.02 for FY2024, which is 9733.76% up from last year.
- Fennec Pharmaceuticals' EPS (Weighted Average and Diluted) amounted to -$0.02 in Q3 2025, which was up 9047.62% from -$0.11 recorded in Q2 2025.
- Fennec Pharmaceuticals' 5-year EPS (Weighted Average and Diluted) high stood at $0.41 for Q1 2024, and its period low was -$0.4 during Q4 2022.
- For the 5-year period, Fennec Pharmaceuticals' EPS (Weighted Average and Diluted) averaged around -$0.13, with its median value being -$0.16 (2021).
- Examining YoY changes over the last 5 years, Fennec Pharmaceuticals' EPS (Weighted Average and Diluted) showed a top increase of 27826.09% in 2024 and a maximum decrease of 20000.0% in 2024.
- Over the past 5 years, Fennec Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.16 in 2021, then plummeted by 150.0% to -$0.4 in 2022, then soared by 75.0% to -$0.1 in 2023, then skyrocketed by 45.01% to -$0.05 in 2024, then soared by 63.63% to -$0.02 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.02 in Q3 2025, compared to -$0.11 in Q2 2025 and -$0.04 in Q1 2025.